loader from loading.io

In the News... Walmart's new insulin, Omnipod 5 studies, stem cell updates & more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

Release Date: 07/02/2021

In the News... Implantable insulin pump, Doctors (not parents) miss T1D symptoms, Dexcom shelf-life extension and more! show art In the News... Implantable insulin pump, Doctors (not parents) miss T1D symptoms, Dexcom shelf-life extension and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It's "In the News..." the only diabetes newscast! Top stories this week: Medtronic moves on implantable insulin pump, study: doctors - but not parents - are missing symptoms of T1D in kids, Dexcom "shelf-life extension" explained, news about whether COVID is causing a surge of diabetes in children and what happened with the Apple watch BG monitoring news? -- Join us each Wednesday at 4:30pm EDT! ----- available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go!        Transcription Below:    Hello and...

info_outline
From American Idol to Actor and Advocate: Meet Kevin Covais show art From American Idol to Actor and Advocate: Meet Kevin Covais

Diabetes Connections with Stacey Simms Type 1 Diabetes

Kevin Covais was one of the youngest contestants on American Idol; he was just 16 when he made his debut during season 5. He’ll share some behind the scenes stories including managing low blood sugar during a live performance. Diagnosed with T1D at age 11, Kevin has been working steadily as an actor. We’ll talk about working in Hollywood with diabetes – and what that's been like during COVID, more about American Idol, and how Kevin found himself mentoring other kids with type 1. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your...

info_outline
In the News.. BG trends during COVID lockdowns, diabetes sales fraud, A Dexcom G5 message, and more! show art In the News.. BG trends during COVID lockdowns, diabetes sales fraud, A Dexcom G5 message, and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It's In the News... the top diabetes stories of the past seven days! This week, what did lockdown mean for BG trends, Provention Bio keeps fighting for Teplizumab, the FTC shuts down diabetes schlockmeisters and if you're still using the Dexcom G5 - you need to hear this... Join Stacey live on Facebook each Wednesday at 4:30pm EDT to watch live. ----- available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go!        Episode transcription and links below Hello and welcome to Diabetes Connections In the News! I’m...

info_outline
The New Walmart Insulin: Everything You Need to Know show art The New Walmart Insulin: Everything You Need to Know

Diabetes Connections with Stacey Simms Type 1 Diabetes

The term “Walmart Insulin” has always referred to cheap, older formulations. But now an agreement with Novo Nordisk means Walmart is selling own branded version of Novolog. It's the very same insulin, with a much lower cash price. What does this mean for us as customers and for insulin pricing overall? Stacey speaks to Michael Burke, Walmart's Director of Brand Pharmacy Merchandising. They talk about who can get Relion Novolog, how much it costs, what your endo needs to know and how insurers are reacting. www.getinsulin.org Stacey mentions (we need your voice!) This podcast is not...

info_outline
In the News... new info on COVID and diabetes, bioartificial pancreas research, a T1D superhero movie and more! show art In the News... new info on COVID and diabetes, bioartificial pancreas research, a T1D superhero movie and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It's "In the News..." the top diabetes headlines of the past seven days. This week: Why is COVID more dangerous with diabetes? A new study says technology (like pumps and CGMs) doesn't help "Diabetes Distress," more screening recommended for "social risk" of type 2, bioartificial pancreas research and there's a T1D Superhero movie in the works! -- Links and transcript below ----- available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go!          Hello and welcome to Diabetes Connections In the News!...

info_outline
Pulled from a meet for his CGM's tape, a high school swimmer with T1D speaks out show art Pulled from a meet for his CGM's tape, a high school swimmer with T1D speaks out

Diabetes Connections with Stacey Simms Type 1 Diabetes

A high school swimmer with diabetes is told he can’t compete at the state championships because of his CGM’s medical tape. It's a story that's been all over social media and national news outlets. What really happened here? We talk to Ethan Orr and his mother, Amanda Terrell-Orr. They explain  what happened that day, what they’d like to see change and what we can all do to protect our rights when it comes to diabetes. Also this week! Send us your "Dear Dr. Banting" audio! This podcast is not intended as medical advice. If you have those kinds of questions, please contact your...

info_outline
In the News.. CGM Disqualifies High School Swimmer, Dexcom Smoothing, T2 Remission and more! show art In the News.. CGM Disqualifies High School Swimmer, Dexcom Smoothing, T2 Remission and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

This week "In the News.." Did wearing a CGM in the water disqualify a high school swimmer? What his family says happened and why they're suing. The ADA wants to start using the word "remission" instead of "reversed" for type 2 diabetes - we'll talk about why. Dexcom says they are no long smoothing data, new migraine and diabetes research and T1Interntioanl is out with their latest survey results about the price and use of insulin. each Wednesday at 4:30pm EDT! ----- available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go!  ...

info_outline
All About Afrezza Inhalable Insulin with CEO Mike Castagna show art All About Afrezza Inhalable Insulin with CEO Mike Castagna

Diabetes Connections with Stacey Simms Type 1 Diabetes

How much do you really know about the only inhalable insulin? This week, Stacey interviews the CEO of MannKind, makers of Afrezza. Mike Castagna talks about how Afrezza works, misconceptions about the product, the worldwide market, pediatric studies and lots more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. ----- available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go!        Episode transcription below: Stacey Simms  0:00...

info_outline
In the News.. type 2 youth study, mini glucagon made easier, CGM via radio waves and more! show art In the News.. type 2 youth study, mini glucagon made easier, CGM via radio waves and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

It's "In the News..." the only LIVE diabetes newscast! -- Top stories this week: T2D screening guidelines to change New Gvoke Kit approved Gestational Diabetes cases up in younger women Are magnets & radio waves coming to T1D care? Update on -- Links and sources in the transcript ----- available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go!        Episode Transcript below:   Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of...

info_outline
"It's Been Like a Dream Come True" Kyle R. Banks, Broadway Performer with T1D

Diabetes Connections with Stacey Simms Type 1 Diabetes

Kyle Banks is a Broadway performer – singer, dancer, actor – he was diagnosed with type 1  while in a production of the Lion King and had to figure out – pretty much on his own – how to  manage on stage. Kyle explains how he learned what he needed to do to perform at his best and shares stories about his time on stage with T1D. Now Kyle has started a foundation to help get diabetes technology into the hands of more people who need it. Plus, some feedback about our last episode.. and a little bit about back to school. This podcast is not intended as medical advice. If you...

info_outline
 
More Episodes
It's "In the News..." the only LIVE diabetes newscast!
Top stories this week:
Walmart private label insulin, Omnipod 5 pediatric study, Afrezza pediatric study, Stem cell updates, A new extreme challenge for a T1D ultra-athlete
Join Stacey live each Wednesday at 4:30pm EDT at the Diabetes Connections Facebook page

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Transcription below: 

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time.

XX

In the News is brought to you by Inside the Breakthrough. A new history of science podcast full of “Did You Know… Stuff”

XX

The top story this week - Walmart launches the first-ever and only private brand analog insulin at a discount off the list price.

This new brand ReliOn Novolog will have vials priced at $72 and a package of pens at $85 – compared to the list price of $289 and $558 respectively

Walmart worked directly with Novo Nordisk for the manufacturing of this insulin which will be in regular stores this week and in Sam's Club locations in mid-July.

Interestingly, this price is not below the one offered already by using coupons from groups like GoodRX or even the insulin manufacturers assistance programs. If you need help paying for your insulin, I’ll link up more info on that as well.

https://finance.yahoo.com/news/walmart-launches-private-label-insulin-at-discount-122021367.html?ncid=twitter_yfsocialtw_l1gbd0noiom

https://www.goodrx.com/novolog

XX

As expected, loads of info and studies from the ADA scientific sessions virtual conference that just wrapped up. Please check the links I’ll include because these are just highlights.

XX

Insulet is out with the results of their latest pivotal trial for the Omnipod 5 Automated Insulin Delivery System in very young children. The system improved time in range and reduced A1C in children 2 through just under six. I can tell you from experience, this is a tough age group for many reasons, including the fact that they can’t self-treat or really tell you what’s going on.

Parents and caregivers reported significantly improved sleep quality

Another Omipod 5 study with people aged 6 through 70 showed similar improvements. The system is awaiting FDA approval.

XX

ViaCyte, Inc. released preliminary clinical data from its stem cell-derived islet cell replacement therapy for people with type 1 diabetes. They show the implanted pancreatic cells produced their own insulin – which increase glucose-responsive C-peptide levels, increased time in range, and reduced A1C.

This method protects the stem cells in a pouch – that’s put very simply – Viactye is working on several different methods toward a functional cure.

https://www.prnewswire.com/news-releases/viacyte-reports-compelling-preliminary-clinical-data-from-islet-cell-replacement-therapy-for-patients-with-type-1-diabetes-301320084.html

XX

Another company on the same track.. Sernova Corp also showing their  Cell Pouch transplanted with insulin-producing islets is safe and effective. One patient has finished the trial and has now remained insulin independent – that means no requirement for injectable insulin - for 14 months with optimal glucose control.

This is a person who’s lived with type 1 for 47 years..

https://www.thenewswire.com/press-releases/1k3wFKYMv-sernovas-principal-investigator-presents-interim-data-and-positive-patient-outcomes-of-phase-i-ii-t1d-study-at-the-american-diabetes-association-81st-scientific-sessions.html

XX

More from ADA conference - In two small studies, the ultra-rapid acting insulin Afrezza was found to be safe in children with type 1 and adults with type 2 diabetes.

Inhalable insulin is currently only approved for adults so the goal here was to look at safety.. which looks good. But it’s also worth noting that . Time in Range increased from 39% at baseline to 62% which is more than four additional hours spent in range each day!

https://diatribe.org/top-highlights-day-1-ada-scientific-sessions-2021

XX

New info in on Medtronic’s Extended-Wear Infusion Set. This is the pump inset that lasts seven days. This study shows that 75% of the time it makes it to the full seven days – Medtronic’s 3 day infusion sets have a 67% survival rate.

Device failure rates were very low – 8 cases out of more than 3-thousand sessions. Satisfaction was high – with people citing convenience of use, ease of insertion, and comfort of wear. This extended wear set is approved in Europe, available in Finland and has been submitted to the US FDA.

https://diatribe.org/day-2-3-highlights-ada-scientific-sessions-2021

 

XX

More to come, including news on Control IQ and an endurance athlete starts an amazing new trek.. but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.

  • Inside the Breakthrough is a podcast that mixes historical wisdom with modern insight – it’s a science show that’s also entertaining. I love it. They cover everything from snake oil to the actual Eureka moment. There’s even an episode about the guy who discovered the importance of hand washing in hospitals and how no one believed him. And this all actually relates to diabetes! Listen to Inside the Breakthrough wherever you listen to podcasts..

Back to the news…

XX

Control-IQ continues to get high marks. This study looked at adults with an average age of 70 who already had A1Cs around 6.9. Three months after staring Control IQ, time in range increased from 64% to 87% which is 5 and a half hours more each day.  All of these adults had prior experience with continuous glucose monitoring and insulin pumps.

XX

Former guest of the podcast, Sébastien Sasseville, is off on a mission to cycle across Canada in 14 days! Sasseville is a Canadian endurance athlete – he lives with type 1 -  and it’s going to take about 250 miles a day to get to this goal.

Sasseville says he’s riding to bring attention to the issue of access to technology – he uses the tslim x2 and Dexcom G6 – and to support JDRF Canada’s Access for All campaign. He set off on June 28th and is documenting the journey on social media.

 

Sebastien Sasseville cycles across Canada: https://www.facebook.com/CanadaRuns.

 

That’s Diabetes Connections – In the News.  If you like it, share it. And feel free to send me your news tips. Stacey @ diabetes dash connections dot com.

Please join me wherever you get podcasts for our next episode -Tuesday –  a conversation with Dexcom’s CEO all about the upcoming G7.. I asked him all of your questions.

Our current episode out right now is with Nick Jonas – sharing his thoughts on the new campaign to educate about Time in Range and talking about he manages his T1D during concerts, shooting movies and during TV tapings.

Thanks and I’ll see you soon